J. B. Chemicals & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
November 07, 2023 at 05:02 am EST
Share
J. B. Chemicals & Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 8,817.4 million compared to INR 8,094.4 million a year ago. Revenue was INR 8,894 million compared to INR 8,107.8 million a year ago. Net income was INR 1,505.9 million compared to INR 1,110.8 million a year ago. Basic earnings per share from continuing operations was INR 9.72 compared to INR 7.19 a year ago. Diluted earnings per share from continuing operations was INR 9.54 compared to INR 7.13 a year ago.
For the six months, sales was INR 17,779.4 million compared to INR 15,942.5 million a year ago. Revenue was INR 17,912.3 million compared to INR 15,964.8 million a year ago. Net income was INR 2,929 million compared to INR 2,161.1 million a year ago. Basic earnings per share from continuing operations was INR 18.92 compared to INR 13.98 a year ago. Diluted earnings per share from continuing operations was INR 18.56 compared to INR 13.88 a year ago.
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
J. B. CHEMICALS & PHARMACEUTICALS LIMITED 
